Tyra Biosciences, Inc.TYRANASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank50
3Y CAGR-32.5%
5Y CAGR+38.4%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
-32.5%/yr
Annual compound
5Y CAGR
+38.4%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
5.1x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$77.39M-15.9%
2024$91.97M+58.5%
2023$58.01M-76.9%
2022$251.21M-16.9%
2021$302.18M+1884.9%
2020$15.22M+13996.3%
2019$108000.00-